Diagnostics

  • InnotiveDx secures £1m for rapid UTI test development

    Bath-based InnotiveDx has won a £1m grant to advance its rapid UTI test, delivering results in under 60 minutes. The funding from PACE (Pathways to Antimicrobial Clinical Efficacy) will support development of the InnotiveUTI test, which provides bacterial identification and antimicrobial susceptibility testing (checking which antibiotics will work) at the point of care. This tackles [...]

  • Prostate cancer screening programme set for Gov approval

    The NHS’s first prostate cancer screening programme could receive approval this week from the government’s National Screening Committee. The National Screening Committee (NSC) meets on Thursday to decide whether to introduce wider screening to detect disease earlier. Any rollout would likely focus on those at highest risk, including people with a family history or specific [...]

  • Pinprick tests could predict disease 10 years before symptoms

    New pinprick blood tests could detect early signs of disease more than 10 years before symptoms appear, following analysis of samples from 500,000 people. The tests are being developed after researchers completed measurements of nearly 250 different proteins, sugars, fats and other compounds in blood collected from half a million volunteers. These molecular profiles provide [...]

  • Diagnostics delivery: How Magentus supports the NHS Medium-Term Planning Framework

    The NHS England Medium-Term Planning Framework 2026–2029 sets out a vision for transforming how care is delivered. With targets like treating 92 per cent of patients within 18 weeks, reducing diagnostic waits to under six weeks for 99 per cent of patients, and treating 85 per cent of cancer patients within 62 days, the Framework [...]

  • Experts weigh targeted prostate cancer screening to cut UK deaths

    Prostate cancer screening could reduce deaths by 13 per cent, research has revealed, prompting UK experts to assess whether to introduce a national screening programme. Cancer screening specialists are reviewing the evidence, with a decision expected before the end of the year on whether routine prostate testing should be introduced across the UK. A new [...]

  • Ground-breaking ceremony marks start of £17.8m Bridgwater Diagnostic Centre

    Ergéa UK was proud to join clinical leaders from Somerset NHS Foundation Trust and Actiform at the ground-breaking ceremony for the new Bridgwater Community Diagnostic Centre -  a milestone moment in our long-term partnership with the Trust. The project recently received conditional planning approval, paving the way for the new facility to welcome its first [...]

  • NHS to pilot AI giving same-day prostate cancer results

    Men checked for prostate cancer on the NHS could soon get same-day results, with artificial intelligence processing MRI scans in seconds under new pilot schemes. Patients assessed by the AI as high risk would be sent straight to a radiologist for an on-the-spot biopsy – a tissue test to confirm whether cancer is present. Results [...]

  • Oxygen deprivation heightens risk of illness by changing genes, study reveals

    Low oxygen levels can alter immune cell genes, weakening the body’s ability to fight infection even after oxygen levels return to normal, new research has revealed. Scientists found that oxygen deprivation – known as hypoxia – changes the genetic material of neutrophils, white blood cells that form one of the body’s first lines of defence [...]

  • Europe celebrates the heart of healthcare decision-making as laboratory medicine professionals take centre stage

    On 5th November 2025, the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) proudly marks its 4th European Laboratory Day, celebrating the professionals at the heart of healthcare decision-making. Across Europe, laboratories will open their doors to showcase the science, innovation and dedication that underpin medical decisions and shape better health outcomes for all. [...]

  • Researchers develop first accurate blood test for chronic fatigue syndrome

    Scientists say they have developed the first blood test to diagnose chronic fatigue syndrome, though experts warn further studies are needed. The test could change how doctors identify myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) – a debilitating illness marked by extreme tiredness not eased by rest. There is currently no diagnostic test, and many patients face [...]